Overview

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, randomized (a process that is used to decide whether you will take study drug or a placebo during the study), inpatient study which will assess the safety and tolerability of HTC-867 in healthy male Japanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer